Basal cell carcinoma MRI: Difference between revisions
Jump to navigation
Jump to search
| Line 5: | Line 5: | ||
==Overview== | ==Overview== | ||
[[MRI]] is useful when the [[tumor]] has any adjacent [[Bone or cartilage mass|bony]] or perineural [[invasion]]. On [[T1]]- it appears as an enhancing isointense [[lesion]]. On [[MRI|T2]]- it appears as an hyperintense [[lesion]]. | |||
[ | |||
==MRI== | ==MRI== | ||
Revision as of 20:14, 5 March 2019
|
Basal cell carcinoma Microchapters |
|
Diagnosis |
|---|
|
Case Studies |
|
Basal cell carcinoma MRI On the Web |
|
American Roentgen Ray Society Images of Basal cell carcinoma MRI |
|
Risk calculators and risk factors for Basal cell carcinoma MRI |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
MRI is useful when the tumor has any adjacent bony or perineural invasion. On T1- it appears as an enhancing isointense lesion. On T2- it appears as an hyperintense lesion.
MRI
- Basal cell carcinoma is usually diagnosed based on history and physical examination
- MRI is useful when the tumor has any adjacent bony or perineural invasion[1]
- On T1- it appears as an enhancing isointense lesion
- On T2- it appears as an hyperintense lesion
References
- ↑ Baheti AD, Tirumani SH, Giardino A, Rosenthal MH, Tirumani H, Krajewski K, Ramaiya NH (February 2015). "Basal cell carcinoma: a comprehensive review for the radiologist". AJR Am J Roentgenol. 204 (2): W132–40. doi:10.2214/AJR.14.13160. PMID 25615773.
Template:Tumors of bone, cartilage, skin, connective, and soft tissue